Patents by Inventor Andrew Borman

Andrew Borman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230267853
    Abstract: An immersive exhibit of video game related interactives includes a periodic table representing a display and a tally of identified activities within predetermined categories in the table. The categories are generic verbs or terms encompassing subsets of interactive video game actions, the identified activities are species, such as the “verbs” or activities of the video games like jump, solve, sort, or punch. A first subset of the plurality of video game related interactives are physically located within a first gallery representing a first category and a second subset of video game related interactives are physically located within a second gallery of the exhibit. An objective of the exhibit is the completion of identified activities in the periodic table by interacting with the video game related interactives having the identified activities.
    Type: Application
    Filed: February 21, 2023
    Publication date: August 24, 2023
    Inventors: Jon-Paul C. Dyson, Elliot Drury, Daniel Resch, Andrew Borman, Byron T. Fong
  • Patent number: 8236324
    Abstract: An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognized by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: August 7, 2012
    Assignee: Institut Pasteur
    Inventors: Pierre Charneau, François Clavel, Andrew Borman, Caroline Quillent, Denise Guetard, Luc Montagnier, Jacqueline Donjon de Saint-Martin, Jacques Cohen
  • Publication number: 20080261197
    Abstract: An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.
    Type: Application
    Filed: November 2, 2006
    Publication date: October 23, 2008
    Inventors: Pierre Charneau, Francois Clavel, Andrew Borman, Caroline Quillent, Denise Guetard, Luc Montagnier, Jacqueline Donjon De Saint-Martin, Jacques H.M. Cohen
  • Patent number: 7157225
    Abstract: An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.
    Type: Grant
    Filed: December 27, 2001
    Date of Patent: January 2, 2007
    Assignee: Institut Pasteur
    Inventors: Pierre Charneau, François Clavel, Andrew Borman, Caroline Quillent, Denise Guetard, Luc Montagnier, Jacqueline Donjon De Saint-Martin, Jacques H. M. Cohen
  • Publication number: 20030049604
    Abstract: An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.
    Type: Application
    Filed: December 27, 2001
    Publication date: March 13, 2003
    Applicant: Institut Pasteur
    Inventors: Pierre Charneau, Francois Clavel, Andrew Borman, Caroline Quillent, Denise Guetard, Luc Montagnier, Jacqueline Donjon De Saint-Martin, Jacques H.M. Cohen
  • Patent number: 6399294
    Abstract: An HIV-1 type (or subtype) O retrovirus protein, or a natural or synthetic polypeptide or peptide including at least a part of said protein, which is capable of being recognised by antibodies isolated from a serum resulting from infection by an HIV-1 type O VAU strain or an HIV-1 type (or subtype) O DUR strain.
    Type: Grant
    Filed: July 11, 1997
    Date of Patent: June 4, 2002
    Assignee: Institut Pasteur
    Inventors: Pierre Charneau, François Clavel, Andrew Borman, Caroline Quillent, Denise Guetard, Luc Montagnier, Jacqueline Donjon De Saint-Martin, Jacques Cohen